Amelioration of Severe TNBS Induced Colitis by Novel AP-1 and NF-κB Inhibitors in Rats

Figure 1

The body weight loss at the end-point of the experiment in controls, DTCM-G-treated, and DHMEQ-treated groups.^∗∗∗𝑃<0.0001 versus controls.